Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Leyton

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Peptides|April 9, 1998
(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumorsT W Moody, J Leyton, E Unsworth, et al.
Cancer Research|July 15, 1994
Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned mediumJ Leyton, M J Manyak, A B Mukherjee, et al.
Cancer Letters|December 21, 2000
Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cellsJ Leyton, L J Garcia-Marin, J A Tapia, et al.
Cancer Letters|May 5, 1998
PACAP(6-38) inhibits the growth of prostate cancer cellsJ Leyton, T Coelho, D H Coy, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 1, 1991
Modulation of phorbol ester-elicited events in mouse epidermis by dietary n-3 and n-6 fatty acidsM A Belury, J Leyton, K E Patrick, et al.
Life Sciences|February 12, 2000
(N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell linesH Zia, J Leyton, M Casibang, et al.
Breast Cancer Research and Treatment|November 26, 1999
PACAP(6-38) is a PACAP receptor antagonist for breast cancer cellsJ Leyton, Y Gozes, J Pisegna, et al.
Breast Cancer Research and Treatment|October 27, 2001
VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cellsT W Moody, J Leyton, D Chan, et al.
Cancer Research|February 1, 1991
Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skinJ Leyton, M L Lee, M Locniskar, et al.
Life Sciences|January 1, 1997
PACAP hybrid: a new PACAP receptor antagonistJ R Pisegna, J Leyton, T Coelho, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Peptides|April 9, 1998
(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumorsT W Moody, J Leyton, E Unsworth, et al.
Cancer Research|July 15, 1994
Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned mediumJ Leyton, M J Manyak, A B Mukherjee, et al.
Cancer Letters|December 21, 2000
Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cellsJ Leyton, L J Garcia-Marin, J A Tapia, et al.
Cancer Letters|May 5, 1998
PACAP(6-38) inhibits the growth of prostate cancer cellsJ Leyton, T Coelho, D H Coy, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 1, 1991
Modulation of phorbol ester-elicited events in mouse epidermis by dietary n-3 and n-6 fatty acidsM A Belury, J Leyton, K E Patrick, et al.
Life Sciences|February 12, 2000
(N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell linesH Zia, J Leyton, M Casibang, et al.
Breast Cancer Research and Treatment|November 26, 1999
PACAP(6-38) is a PACAP receptor antagonist for breast cancer cellsJ Leyton, Y Gozes, J Pisegna, et al.
Breast Cancer Research and Treatment|October 27, 2001
VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cellsT W Moody, J Leyton, D Chan, et al.
Cancer Research|February 1, 1991
Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skinJ Leyton, M L Lee, M Locniskar, et al.
Life Sciences|January 1, 1997
PACAP hybrid: a new PACAP receptor antagonistJ R Pisegna, J Leyton, T Coelho, et al.
Pageof 3